Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $1.4 million.

  • Upstream Bio's Change in Account Payables rose 90517.24% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$926000.0, marking a year-over-year decrease of 11993.54%. This contributed to the annual value of $2.0 million for FY2024, which is 5782.47% up from last year.
  • Upstream Bio's Change in Account Payables amounted to $1.4 million in Q3 2025, which was up 90517.24% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Change in Account Payables registered a high of $3.7 million during Q2 2024, and its lowest value of -$2.2 million during Q2 2025.
  • In the last 3 years, Upstream Bio's Change in Account Payables had a median value of $268500.0 in 2024 and averaged $464875.0.
  • Within the past 5 years, the most significant YoY rise in Upstream Bio's Change in Account Payables was 90517.24% (2025), while the steepest drop was 15893.39% (2025).
  • Upstream Bio's Change in Account Payables (Quarter) stood at $1.8 million in 2023, then tumbled by 149.57% to -$871000.0 in 2024, then surged by 260.85% to $1.4 million in 2025.
  • Its Change in Account Payables stands at $1.4 million for Q3 2025, versus -$2.2 million for Q2 2025 and $711000.0 for Q1 2025.